TAKEDA CAMBRIDGE LIMITED

Active Cambridge

Other letting and operating of own or leased real estate

0 employees website.com
Life sciences and medical technology Other letting and operating of own or leased real estate
T

TAKEDA CAMBRIDGE LIMITED

Other letting and operating of own or leased real estate

Founded 23 Jun 1998 Active Cambridge, United Kingdom 0 employees website.com
Life sciences and medical technology Other letting and operating of own or leased real estate

Previous Company Names

PARADIGM THERAPEUTICS LIMITED 23 Jun 1998 — 30 Mar 2007
Accounts Submitted 4 Jan 2026 Next due 31 Dec 2026 7 months remaining
Confirmation Submitted 27 Jun 2025 Next due 7 Jul 2026 1 month remaining
Net assets £4M £342K 2024 year on year
Total assets £13M £1M 2024 year on year
Total Liabilities £9M £1M 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

418 Cambridge Science Park Milton Road Cambridge CB4 0PZ

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for TAKEDA CAMBRIDGE LIMITED (03585995), an active life sciences and medical technology company based in Cambridge, United Kingdom. Incorporated 23 Jun 1998. Other letting and operating of own or leased real estate. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Apr → 31 Mar 2025
Type full
Next accounts 31 Mar 2026
Due by 31 Dec 2026 7 months remaining

Balance Sheet & P&L (2013–2024)

Cash in Bank

£684.00k

Decreased by £501.00k (-42%)

Net Assets

£3.86M

Increased by £342.00k (+10%)

Total Liabilities

£8.74M

Decreased by £1.38M (-14%)

Turnover

£1.75M

Employees

N/A

Debt Ratio

69%

Decreased by 5 (-7%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
31 Mar Year End
2024
31 Mar Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

1 active 2 resigned
Status
Marc Stuart PageDirectorBritishUnited Kingdom4128 Apr 2021Active

Shareholders

Shareholders (1)

Takeda Pharmaceutical Company Limited
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Takeda Pharmaceutical Company Limited

Japan

Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

TAKEDA CAMBRIDGE LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

1 leasehold 1 total
AddressTenurePrice PaidDate Added
Unit 418, Science Park, Milton Road, Cambridge (CB4 0WE) SOUTH CAMBRIDGESHIRE
Leasehold-28 Feb 2014
Unit 418, Science Park, Milton Road, Cambridge (CB4 0WE)
Leasehold
Added 28 Feb 2014
District SOUTH CAMBRIDGESHIRE

Documents

Company Filings

DateCategoryDescriptionDocument
4 Jan 2026AccountsAnnual accounts made up to 31 Mar 2025
7 Nov 2025OfficersAppointment of Itaru Miura as director on 4 Nov 2025
8 Sept 2025OfficersAppointment of Seyda Atadan Memis as director on 31 Aug 2025
5 Sept 2025OfficersTermination of Peter Michael Grubin as director on 31 Aug 2025
11 Jul 2025OfficersChange to director Mr Peter Michael Grubin on 29 May 2025
4 Jan 2026 Accounts

Annual accounts made up to 31 Mar 2025

7 Nov 2025 Officers

Appointment of Itaru Miura as director on 4 Nov 2025

8 Sept 2025 Officers

Appointment of Seyda Atadan Memis as director on 31 Aug 2025

5 Sept 2025 Officers

Termination of Peter Michael Grubin as director on 31 Aug 2025

11 Jul 2025 Officers

Change to director Mr Peter Michael Grubin on 29 May 2025

Recent Activity

Latest Activity

Annual accounts made up to 31 Mar 2025

4 months ago on 4 Jan 2026

Appointment of Itaru Miura as director on 4 Nov 2025

6 months ago on 7 Nov 2025

Appointment of Seyda Atadan Memis as director on 31 Aug 2025

8 months ago on 8 Sept 2025

Termination of Peter Michael Grubin as director on 31 Aug 2025

8 months ago on 5 Sept 2025

Change to director Mr Peter Michael Grubin on 29 May 2025

10 months ago on 11 Jul 2025